This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Information on how to access Fragmin® (dalteparin sodium) prescribing information and adverse event reporting can be found at the bottom of the page.

Risk Factors: Unstable Angina and NSTEMI

If UA and NSTEMI are untreated after a firm diagnosis, the prognosis is poor and mortality high, particularly in patients with myocardial damage1

​​​​​​​Appropriate triage, risk assessment and timely use of acute pharmacological and invasive interventions is critical in preventing future cardiovascular events (MI, stroke, repeat revascularisation and death)

Unstable Angina and NSTEMI

Fragmin Tolerability

Find out more

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No